Live feed
Filing
SC 13G
SC 13G0001477932-18-006022·Climate Change Investigation, Innovation & Investment Compan
Schedule 13G ownership disclosure
CURE PHARMA HOLDING CORP COM
Security class unavailable · CUSIP: 23127P104
Event date: 2016-11-07
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 13.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001477932-18-006022
- Form type
- SC 13G
- Filer
- Climate Change Investigation, Innovation & Investment Compan
- CIK
- CIK 1759122
- Filed
- Dec 17, 2018
- Reporting period
- Nov 07, 2016
- Description
- Schedule 13G beneficial ownership